Precision Medicine

How Does Epigenetic Plasticity Drive Cancer Drug Resistance?
Research & Development How Does Epigenetic Plasticity Drive Cancer Drug Resistance?

When a patient undergoes targeted therapy, the initial results often seem nothing short of a medical miracle as tumors rapidly shrink and symptoms vanish, yet this reprieve is frequently cut short by a clandestine survival mechanism that modern science is only now beginning to fully decode. For

Can Sana Biotechnology Revolutionize Diabetes Care?
Research & Development Can Sana Biotechnology Revolutionize Diabetes Care?

The chronic burden of managing insulin-dependent diabetes has historically demanded a relentless cycle of blood glucose monitoring and hormonal injections that rarely achieve perfect physiological balance. Despite significant advancements in insulin delivery systems and continuous glucose monitors,

Could CD83 CAR T Cells Treat AML and Prevent GVHD?
Research & Development Could CD83 CAR T Cells Treat AML and Prevent GVHD?

The landscape of hematological oncology is currently witnessing a transformative shift as clinicians move beyond traditional chemotherapy toward precision-engineered cellular therapies that can distinguish between malignant and healthy tissues with unprecedented accuracy. This evolution is

Researchers Awarded $1.5 Million to Target Lung Cancer Cure
Research & Development Researchers Awarded $1.5 Million to Target Lung Cancer Cure

The persistent evolution of drug-resistant tumors has long remained the primary barrier to achieving a definitive cure for lung cancer patients who initially respond well to therapy. While modern medicine successfully transformed many terminal diagnoses into manageable chronic conditions, certain

Long COVID Immunoproteomics – Review
Tech & Innovation Long COVID Immunoproteomics – Review

The intricate dance between the human immune system and the ghost of a viral past is finally becoming visible through the lens of high-resolution immunoproteomics, a field that is effectively ending the era of diagnostic ambiguity for millions. This technological evolution represents a fundamental

AI and Registry Data Identify High-Risk Melanoma Patients
Tech & Innovation AI and Registry Data Identify High-Risk Melanoma Patients

The silent progression of melanoma often remains undetected until it reaches a critical stage, yet the digital fingerprints of this disease may already exist within the vast archives of national healthcare databases. A transformative study led by researchers at the University of Gothenburg and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later